HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

Genentech, one of the world's premiere biotechnology companies headquartered in South San Francisco, California, announced it ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

North Carolina's life sciences sector continues to attract major investments with the potential for thousands of jobs.

North Carolina state leaders announced a major deal to invest $700 million in a manufacturing plant in Wake County, bringing ...

Governor Josh Stein announced Genentech's plan to build a new $700M biotech facility in North Carolina, creating 400 jobs.

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...